Mitochondrial dysfunction and defects in lipid homeostasis as therapeutic targets in neurodegeneration with brain iron accumulation

References

• Morgan NV, Westaway SK, Morton JE, Gregory A, Gissen P, Sonek S, Cangul H, Coryell J, Canham N, Nardocci N, et al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 2006; 38:752-4; PMID:16783378; http://dx.doi.org/10.1038/ng1826
   Google Scholar
• Khateeb S, Flusser H, Ofir R, Shelef I, Narkis G, Vardi G, Shorer Z, Levy R, Galil A, Elbedour K, et al. PLA2G6 mutation underlies infantile neuroaxonal dystrophy. Am J Hum Genet 2006; 79:942-8; PMID:17033970; http://dx.doi.org/10.1086/508572
   Google Scholar
• Gregory A, Westaway SK, Holm IE, Kotzbauer PT, Hogarth P, Sonek S, Coryell JC, Nguyen TM, Nardocci N, Zorzi G, et al. Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology 2008; 71:1402-9; PMID:18799783; http://dx.doi.org/10.1212/01.wnl.0000327094.67726.28
   Google Scholar
• Winstead MV1, Balsinde J, Dennis EA. Calcium-independent phospholipase A(2): structure and function. Biochim Biophys Acta 2000; 1488:28-39; PMID:11080674; http://dx.doi.org/10.1016/S1388-1981(00)00107-4
   Google Scholar
• Burke JE, Dennis EA. Phospholipase A2 biochemistry. Cardiovasc Drugs Ther 2009; 23:49-59; PMID:18931897; http://dx.doi.org/10.1007/s10557-008-6132-9
   Google Scholar
• Ong WY, Yeo JF, Ling SF, Farooqui AA. Distribution of calcium-independent phospholipase A2 (iPLA 2) in monkey brain. J Neurocytol 2005; 34:447-58; PMID:16902765; http://dx.doi.org/10.1007/s11068-006-8730-4
   Google Scholar
• Williams, SD and Gottlieb, RA. Inhibition of mitochondrial calcium-independent phospholipase A(2) (iPLA(2)) attenuates mitochondrial phospholipid loss and is cardioprotective. J Biochem 2002; 362:23-32; http://dx.doi.org/10.1042/bj3620023
   Google Scholar
• Seleznev K, Zhao C, Zhang XH, Song K, Ma ZA. Calcium-independent phospholipase A2 localizes in and protects mitochondria during apoptotic induction by staurosporine. J Biol Chem 2006; 281:22275-88; PMID:16728389; http://dx.doi.org/10.1074/jbc.M604330200
   Google Scholar
• Song H1, Bao S, Lei X, Jin C, Zhang S, Turk J, Ramanadham S. Evidence for proteolytic processing and stimulated organelle redistribution of iPLA(2)β. Biochim Biophys Acta 2010; 1801:547-58; PMID:20132906; http://dx.doi.org/10.1016/j.bbalip.2010.01.006
   Google Scholar
• Balsinde J, Balboa MA. Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells. Cell Signal 2005; 17:1052-62; PMID:15993747; http://dx.doi.org/10.1016/j.cellsig.2005.03.002
   Google Scholar
• Wang Z, Ramanadham S, Ma ZA, Bao S, Mancuso DJ, Gross RW, Turk J. Group VIA phospholipase A2 forms a signaling complex with the calcium/calmodulin-dependent protein kinase IIbeta expressed in pancreatic islet β-cells. J Biol Chem 2005; 280:6840-9; PMID:15576376; http://dx.doi.org/10.1074/jbc.M405287200
   Google Scholar
• Balsinde J1, Bianco ID, Ackermann EJ, Conde-Frieboes K, Dennis EA. Inhibition of calcium-independent phospholipase A2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages. Proc Natl Acad Sci U S A 1995; 92:8527-31; PMID:7667324; http://dx.doi.org/10.1073/pnas.92.18.8527
   Google Scholar
• Yang HC1, Mosior M, Johnson CA, Chen Y, Dennis EA. Group-specific assays that distinguish between the four major types of mammalian phospholipase A2. Anal Biochem. 1999; 269:278-88; PMID:10221999; http://dx.doi.org/10.1006/abio.1999.4053
   Google Scholar
• Balboa MA1, Balsinde J. Involvement of calcium-independent phospholipase A2 in hydrogen peroxide-induced accumulation of free fatty acids in human U937 cells. J Biol Chem 2002; 277:40384-9; PMID:12181317; http://dx.doi.org/10.1074/jbc.M206155200
   Google Scholar
• Shindou H1, Hishikawa D, Harayama T, Eto M, Shimizu T. Generation of membrane diversity by lysophospholipid acyltransferases. J Biochem 2013; 154:21-8; PMID:23698096; http://dx.doi.org/10.1093/jb/mvt048
   Google Scholar
• Glynn P. Neuronal phospholipid deacylation is essential for axonal and synaptic integrity. Biochim Biophys Acta 2013; 1831:633-41; PMID:22903185; http://dx.doi.org/10.1016/j.bbalip.2012.07.023
   Google Scholar
• Balboa MA, Pérez R, Balsinde J. Calcium-independent phospholipase A2 mediates proliferation of human promonocytic U937 cells. FEBS J 2008; 275:1915-24; PMID:18336573; http://dx.doi.org/10.1111/j.1742-4658.2008.06350.x
   Google Scholar
• Pérez R, Melero R, Balboa MA, Balsinde J. Role of group VIA calcium-independent phospholipase A2 in arachidonic acid release, phospholipid fatty acid incorporation, and apoptosis in U937 cells responding to hydrogen peroxide. J Biol Chem 2004; 279:40385-91; http://dx.doi.org/10.1074/jbc.M402562200
   Google Scholar
• Malaguti MC, Melzi V, Di Giacopo R, Monfrini E, Di Biase E, Franco G, Borellini L, Trezzi I, Monzio Compagnoni G, Fortis P, et al. A novel homozygous PLA2G6 mutation causes dystonia-parkinsonism. Parkinsonism Relat Disord 2015; 21:337-9; PMID:25601130; http://dx.doi.org/10.1016/j.parkreldis.2015.01.001
   Google Scholar
• Xu C, Warsh JJ, Wang KS, Mao CX, Kennedy JL. Association of the iPLA2β gene with bipolar disorder and assessment of its interaction with TRPM2 gene polymorphisms. Psychiatr Genet 2013; 23:86-9; PMID:23277130; http://dx.doi.org/10.1097/YPG.0b013e32835d700d
   Google Scholar
• Ning LF, Yu YQ, GuoJi ET, Kou CG, Wu YH, Shi JP, Ai LZ, Yu Q. Meta-analysis of differentially expressed genes in autism based on gene expression data. Genet Mol Res 2015; 14:2146-55; PMID:25867362; http://dx.doi.org/10.4238/2015.March.27.1
   Google Scholar
• Zhang P, Gao Z, Jiang Y, Wang J, Zhang F, Wang S, Yang Y, Xiong H, Zhang Y, Bao X, et al. Follow-up study of 25 Chinese children with PLA2G6-associated neurodegeneration. Eur J Neurol 2013; 20:322-30; PMID:22934738; http://dx.doi.org/10.1111/j.1468-1331.2012.03856.x
   Google Scholar
• Nardocci N, Zorzi G, Farina L, Binelli S, Scaioli W, Ciano C, Verga L, Angelini L, Savoiardo M, Bugiani O. Infantile neuroaxonal dystrophy: clinical spectrum and diagnostic criteria. Neurology 1999; 52:1472-8; PMID:10227637; http://dx.doi.org/10.1212/WNL.52.7.1472
   Google Scholar
• Riku Y, Ikeuchi T, Yoshino H, Mimuro M, Mano K, Goto Y, Hattori N, Sobue G, Yoshida M. Extensive aggregation of α-synuclein and tau in juvenile-onset neuroaxonal dystrophy: an autopsied individual with a novel mutation in the PLA2G6 gene-splicing site. Acta Neuropathol Commun 2013; 1:12; PMID:24252552; http://dx.doi.org/10.1186/2051-5960-1-12
   Google Scholar
• Biancheri R, Rossi A, Alpigiani G, Filocamo M, Gandolfo C, Lorini R, Minetti C. Cerebellar atrophy without cerebellar cortex hyperintensity in infantile neuroaxonal dystrophy (INAD) due to PLA2G6 mutation. Eur J Paediatr Neurol 2007; 11:175-7; PMID:17254819; http://dx.doi.org/10.1016/j.ejpn.2006.11.013
   Google Scholar
• Kurian MA, Morgan NV, MacPherson L, Foster K, Peake D, Gupta R, Philip SG, Hendriksz C, Morton JE, Kingston HM, et al. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology 2008; 70:1623-9; PMID:18443314; http://dx.doi.org/10.1212/01.wnl.0000310986.48286.8e
   Google Scholar
• Arber CE, Li A, Houlden H, Wray S. Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories. Neuropathol Appl Neurobiol 2015; PMID:25870938; http://dx.doi.org/10.1111/nan.12242
   Google Scholar
• Paisan-Ruiz C, Bhatia KP, Li A, Hernandez D, Davis M, Wood NW, Hardy J, Houlden H, Singleton A, Schneider SA. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol 2009; 65:19-23; PMID:18570303; http://dx.doi.org/10.1002/ana.21415
   Google Scholar
• Shi CH, Tang BS, Wang L, Lv ZY, Wang J, Luo LZ, Shen L, Jiang H, Yan XX, Pan Q, et al. PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort. Neurology 2011; 77:75-81; PMID:21700586; http://dx.doi.org/10.1212/WNL.0b013e318221acd3
   Google Scholar
• Lu CS1, Lai SC, Wu RM, Weng YH, Huang CL, Chen RS, Chang HC, Wu-Chou YH, Yeh TH. PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson disease. Am J Med Genet B Neuropsychiatr Genet 2012; 159B:183-91; PMID:22213678; http://dx.doi.org/10.1002/ajmg.b.32012
   Google Scholar
• Xie F, Cen Z, Ouyang Z, Wu S, Xiao J, Luo W. Homozygous p.D331Y mutation in PLA2G6 in two patients with pure autosomal-recessive early-onset parkinsonism: further evidence of a fourth phenotype of PLA2G6-associated neurodegeneration. Parkinsonism Relat Disord 2015; 21:420-2; PMID:25660576; http://dx.doi.org/10.1016/j.parkreldis.2015.01.012
   Google Scholar
• Kimura T, Fujise N, Ono T, Shono M, Yuzuriha T, Katsuragi S, Takamatsu J, Miyakawa T, Kitamura T. Identification of an aging-related spherical inclusion in the human brain. Pathol Int 2002; 52:636-42; PMID:12445135; http://dx.doi.org/10.1046/j.1440-1827.2002.01402.x
   Google Scholar
• Malik I, Turk J, Mancuso DJ, Montier L, Wohltmann M, Wozniak DF, Schmidt RE, Gross RW, Kotzbauer PT. Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations. Am J Pathol 2008; 172:406-16; PMID:18202189; http://dx.doi.org/10.2353/ajpath.2008.070823
   Google Scholar
• Paisán-Ruiz C, Li A, Schneider S, Holton JL, Johnson R, Kidd D, Chataway J, Bhatia KP, Lees AJ, Hardy J, et al. Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging 2012; 33:814-823; http://dx.doi.org/10.1016/j.neurobiolaging.2010.05.009
   Google Scholar
• Beck G, Sugiura Y, Shinzawa K, Kato S, Setou M, Tsujimoto Y, Sakoda S, Sumi-Akamaru H. Neuroaxonal dystrophy in calcium-independent phospholipase A2β deficiency results from insufficient remodeling and degeneration of mitochondrial and presynaptic membranes. J Neurosci 2011; 31:11411-20; PMID:21813701; http://dx.doi.org/10.1523/JNEUROSCI.0345-11.2011
   Google Scholar
• Engel LA, Jing Z, O'Brien DE, Sun M, Kotzbauer PT. Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism. PLoS One 2010; 5:e12897; PMID:20886109; http://dx.doi.org/10.1371/journal.pone.0012897
   Google Scholar
• Gui YX, Xu ZP, Wen-Lv, Liu HM, Zhao JJ, Hu XY. Four novel rare mutations of PLA2G6 in Chinese population with Parkinson disease. Parkinsonism Relat Disord 2013; 19:21-6; PMID:23182313; http://dx.doi.org/10.1016/j.parkreldis.2012.07.016
   Google Scholar
• Kagan VE, Borisenko GG, Tyurina YY, Tyurin VA, Jiang J, Potapovich AI, Kini V, Amoscato AA, Fujii Y. Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine. Free Radic Biol Med 2004; 37:1963-85; PMID:15544916; http://dx.doi.org/10.1016/j.freeradbiomed.2004.08.016
   Google Scholar
• Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA, Kapralov AA, Kini V, et al. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 2005; 1:223-32; PMID:16408039; http://dx.doi.org/10.1038/nchembio727
   Google Scholar
• Wada H1, Yasuda T, Miura I, Watabe K, Sawa C, Kamijuku H, Kojo S, Taniguchi M, Nishino I, Wakana S, Yoshida H, et al. Establishment of an improved mouse model for infantile neuroaxonal dystrophy that shows early disease onset and bears a point mutation in Pla2g6. Am J Pathol 2009; 175:2257-63; PMID:19893029; http://dx.doi.org/10.2353/ajpath.2009.090343
   Google Scholar
• Cheon Y, Kim HW, Igarashi M, Modi HR, Chang L, Ma K, Greenstein D, Wohltmann M, Turk J, Rapoport SI, et al. Disturbed brain phospholipid and docosahexaenoic acid metabolism in calcium-independent phospholipase A(2)-VIA (iPLA(2)β)-knockout mice. Biochim Biophys Acta 2012; 1821:1278-86; PMID:22349267; http://dx.doi.org/10.1016/j.bbalip.2012.02.003
   Google Scholar
• Strokin M, Seburn KL, Cox GA, Martens KA, Reiser G. Severe disturbance in the Ca2+ signaling in astrocytes from mouse models of human infantile neuroaxonal dystrophy with mutated Pla2g6. Hum Mol Genet 2012; 21:2807-14; PMID:22442204; http://dx.doi.org/10.1093/hmg/dds108
   Google Scholar
• Zhao Z, Wang J, Zhao C, Bi W, Yue Z, Ma ZA. Genetic ablation of PLA2G6 in mice leads to cerebellar atrophy characterized by Purkinje cell loss and glial cell activation. PLoS One 2011; 6:e26991; PMID:22046428; http://dx.doi.org/10.1371/journal.pone.0026991
   Google Scholar
• Shinzawa K, Sumi H, Ikawa M, Matsuoka Y, Okabe M, Sakoda S, Tsujimoto Y. Neuroaxonal dystrophy caused by group VIA phospholipase A2 deficiency in mice: a model of human neurodegenerative disease. J Neurosci 2008; 28:2212-20; PMID:18305254; http://dx.doi.org/10.1523/JNEUROSCI.4354-07.2008
   Google Scholar
• Kinghorn KJ, Castillo-Quan JI, Bartolome F, Angelova PR, Li L, Pope S, Cochemé HM, Khan S, Asghari S, Bhatia KP, et al. Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction. Brain 2015; 138:1801-16; PMID:26001724; http://dx.doi.org/10.1093/brain/awv132
   Google Scholar
• Schlame M. Cardiolipin remodeling and the function of tafazzin. Biochim Biophys Acta 2013; 1831:582-8; PMID:23200781; http://dx.doi.org/10.1016/j.bbalip.2012.11.007
   Google Scholar
• Hill S, Hirano K, Shmanai VV, Marbois BN, Vidovic D, Bekish AV, Kay B, Tse V, Fine J, Clarke CF, et al. Isotope-reinforced polyunsaturated fatty acids protect yeast cells from oxidative stress. Free Radic Biol Med 2011; 50:130-8; PMID:20955788; http://dx.doi.org/10.1016/j.freeradbiomed.2010.10.690
   Google Scholar
• Hill S, Lamberson CR, Xu L, To R, Tsui HS, Shmanai VV, Bekish AV, Awad AM, Marbois BN, Cantor CR, et al. Small amounts of isotope-reinforced polyunsaturated fatty acids suppress lipid autoxidation. Free Radic Biol Med 2012; 53:893-906; PMID:22705367; http://dx.doi.org/10.1016/j.freeradbiomed.2012.06.004
   Google Scholar
• Shchepinov MS, Chou VP, Pollock E, Langston JW, Cantor CR, Molinari RJ, Manning-Boğ AB. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson disease. Toxicol Lett 2011; 207:97-103; PMID:21906664; http://dx.doi.org/10.1016/j.toxlet.2011.07.020
   Google Scholar
• Campanella A, Privitera D, Guaraldo M, Rovelli E, Barzaghi C, Garavaglia B, Santambrogio P, Cozzi A, Levi S. Skin fibroblasts from pantothenate kinase-associated neurodegeneration patients show altered cellular oxidative status and have defective iron-handling properties. Hum Mol Genet 2012; 21:4049-59; PMID:22692681; http://dx.doi.org/10.1093/hmg/dds229
   Google Scholar
• Brunetti D, Dusi S, Morbin M, Uggetti A, Moda F, D'Amato I, Giordano C, d'Amati G, Cozzi A, Levi S, et al. Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model. Hum Mol Genet. 2012; 21(24):5294-305; PMID:22983956; http://dx.doi.org/10.1093/hmg/dds380
   Google Scholar
• Hörtnagel K, Prokisch H, Meitinger T. An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria. Hum Mol Genet 2003; 12(3):321-7; PMID:12554685; http://dx.doi.org/10.1093/hmg/ddg026
   Google Scholar
• Rock CO, Calder RB, Karim MA, Jackowski S. Pantothenate kinase regulation of the intracellular concentration of coenzyme A. J Biol Chem 2000; 275:1377-83; PMID:10625688; http://dx.doi.org/10.1074/jbc.275.2.1377
   Google Scholar
• Perry TL, Norman MG, Yong VW, Whiting S, Crichton JU, Hansen S, Kish SJ. Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Ann Neurol 1985; 18(4):482-9; PMID:4073841; http://dx.doi.org/10.1002/ana.410180411
   Google Scholar
• Bosveld F, Rana A, van der Wouden PE, Lemstra W, Ritsema M, Kampinga HH, Sibon OC. De novo CoA biosynthesis is required to maintain DNA integrity during development of the Drosophila nervous system. Hum Mol Genet 2008; 17:2058-69; PMID:18407920; http://dx.doi.org/10.1093/hmg/ddn105
   Google Scholar
• Rana A, Seinen E, Siudeja K, Muntendam R, Srinivasan B, van der Want JJ, Hayflick S, Reijngoud DJ, Kayser O, Sibon OC. Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration. Proc Natl Acad Sci U S A 2010; 107:6988-93; PMID:20351285; http://dx.doi.org/10.1073/pnas.0912105107
   Google Scholar
• Siudeja K, Srinivasan B, Xu L, Rana A, de Jong J, Nollen EA, Jackowski S, Sanford L, Hayflick S, Sibon OC. Impaired Coenzyme A metabolism affects histone and tubulin acetylation in Drosophila and human cell models of pantothenate kinase associated neurodegeneration. EMBO Mol Med 2011; 3:755-66; PMID:21998097; http://dx.doi.org/10.1002/emmm.201100180
   Google Scholar
• Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 1998; 39(8):1529-42; PMID:9717713
   Google Scholar
• Massey AC, Kiffin R, Cuervo AM. Autophagic defects in aging: looking for an “emergency exit”? Cell Cycle 2006; 5(12):1292-6; PMID:16760669; http://dx.doi.org/10.4161/cc.5.12.2865
   Google Scholar
• Zhyvoloup A, Nemazanyy I, Babich A, Panasyuk G, Pobigailo N, Vudmaska M, Naidenov V, Kukharenko O, Palchevskii S, Savinska L, et al. Molecular cloning of CoA Synthase. The missing link in CoA biosynthesis. J Biol Chem 2002; 277:22107-10; PMID:11980892; http://dx.doi.org/10.1074/jbc.C200195200
   Google Scholar
• Nemazanyy I, Panasyuk G, Breus O, Zhyvoloup A, Filonenko V, Gout IT. Identification of a novel CoA synthase isoform, which is primarily expressed in the brain. Biochem Biophys Res Commun 2006; 341:995-1000; PMID:16460672; http://dx.doi.org/10.1016/j.bbrc.2006.01.051
   Google Scholar
• Dusi S, Valletta L, Haack TB, Tsuchiya Y, Venco P, Pasqualato S, Goffrini P, Tigano M, Demchenko N, Wieland T, Schwarzmayr T, et al. Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation. Am J Hum Genet 2014; 94:11-22; PMID:24360804; http://dx.doi.org/10.1016/j.ajhg.2013.11.008
   Google Scholar
• Rhee HW, Zou P, Udeshi ND, Martell JD, Mootha VK, Carr S.A, Ting AY. Proteomic mapping of mitochondria in living cells via spatially restricted enzymatic tagging. Science 2013; 339:1328-1331; PMID:23371551; http://dx.doi.org/10.1126/science.1230593
   Google Scholar
• Zhyvoloup A, Nemazanyy I, Panasyuk G, Valovka T, Fenton T, Rebholz H, Wang ML, Foxon R, Lyzogubov V, Usenko V, et al. Subcellular localization and regulation of coenzyme A synthase. J Biol Chem 2003; 278:50316-50321; PMID:14514684; http://dx.doi.org/10.1074/jbc.M307763200
   Google Scholar
• Alfonso-Pecchio A, Garcia M, Leonardi R, Jackowski S. Compartmentalization of mammalian pantothenate kinases. PLoS One 2012; 7:e49509; PMID:23152917; http://dx.doi.org/10.1371/journal.pone.0049509
   Google Scholar
• Leoni V, Strittmatter L, Zorzi G, Zibordi F, Dusi S, Garavaglia B, Venco P, Caccia C, Souza AL, Deik A, et al. Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations. Mol Genet Metab 2012; 105:463-71; PMID:22221393; http://dx.doi.org/10.1016/j.ymgme.2011.12.005
   Google Scholar
• Hartig MB, Iuso A, Haack T, Kmiec T, Jurkiewicz E, Heim K, Roeber S, Tarabin V, Dusi S, Krajewska-Walasek M, et al. Absence of an orphan mitochondrial protein, C19orf12, causes a distinct clinical subtype of neuodegeneration with brain iron accumulation. Am J Hum Genet 2011; 89(4):543-50; http://dx.doi.org/10.1016/j.ajhg.2011.09.007
   Google Scholar
• Gagliardi M, Annesi G, Lesca G, Broussolle E, Iannello G, Vaiti V, Gambardella A, Quattrone A. C19orf12 gene mutations in patients with neurodegeneration with brain iron accumulation. Parkinsonism Relat Disord 2015; 21:813-6; PMID:25962551; http://dx.doi.org/10.1016/j.parkreldis.2015.04.009
   Google Scholar
• Kleffner I, Wessling C, Gess B, Korsukewitz C, Allkemper T, Schirmacher A, Young P, Senderek J, Husstedt IW. Behr syndrome with homozygous C19ORF12 mutation. J Neurol Sci 2015; 357:115-8; PMID:26187298; http://dx.doi.org/10.1016/j.jns.2015.07.009
   Google Scholar
• Kruer MC, Salih MA, Mooney C, Alzahrani J, Elmalik SA, Kabiraj MM, Khan AO, Paudel R, Houlden H, Azzedine H, et al. C19orf12 mutation leads to a pallido-pyramidal syndrome. Gene 2014; 537:352-6; PMID:24361204; http://dx.doi.org/10.1016/j.gene.2013.11.039
   Google Scholar
• Landouré G, Zhu PP, Lourenço CM, Johnson JO, Toro C, Bricceno KV, Rinaldi C, Meilleur KG, Sangaré M, Diallo O, et al. Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12. Hum Mutat 2013; 34:1357-60; PMID:Can't; http://dx.doi.org/10.1002/humu.22378
   Google Scholar
• Hogarth P, Gregory A, Kruer MC, Sanford L, Wagoner W, Natowicz MR, Egel RT, Subramony SH, Goldman JG, Berry-Kravis E, et al. New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. Neurology 2013; 80:268-75; PMID:23269600; http://dx.doi.org/10.1212/WNL.0b013e31827e07be
   Google Scholar
• Venco P, Bonora M, Giorgi C, Papaleo E, Iuso A, Prokisch H, Pinton P, Tiranti V. Mutations of C19orf12, coding for a transmembrane glycine zipper containing mitochondrial protein, cause mis-localization of the protein, inability to respond to oxidative stress and increased mitochondrial Ca2. Front Genet 2015; 6:185; PMID:26136767; http://dx.doi.org/10.3389/fgene.2015.00185
   Google Scholar
• Iuso A, Sibon OC, Gorza M, Heim K, Organisti C, Meitinger T, Prokisch H. Impairment of Drosophila orthologs of the human orphan protein C19orf12 induces bang sensitivity and neurodegeneration. PLoS One 2014; 9:e89439; PMID:24586779; http://dx.doi.org/10.1371/journal.pone.0089439
   Google Scholar
• Edvardson S, Hama H, Shaag A, Gomori JM, Berger I, Soffer D, Korman SH, Taustein I, Saada A, Elpeleg O. Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia. Am J Hum Genet 2008; 83:643-8; PMID:19068277
   Google Scholar
• Dick KJ, Eckhardt M, Paisán-Ruiz C, Alshehhi AA, Proukakis C, Sibtain NA, Maier H, Sharifi R, Patton MA, Bashir W, et al. Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35). Hum Mutat 2010; 31:E1251-60; PMID:20104589; http://dx.doi.org/10.1002/humu.21205
   Google Scholar
• Kruer MC, Gregory A, Hayflick SJ. Fatty Acid Hydroxylase-Associated Neurodegeneration. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Smith RJH, Stephens K, editors. GeneReviews® Seattle (WA): University of Washington, Seattle; 1993-2015
   Google Scholar
• Maldonado EN, Alderson NL, Monje PV, Wood PM, Hama H. FA2H is responsible for the formation of 2-hydroxy galactolipids in peripheral nervous system myelin. J Lipid Res 2008; 49:153-61; PMID:17901466; http://dx.doi.org/10.1194/jlr.M700400-JLR200
   Google Scholar
• Eckhardt M, Yaghootfam A, Fewou SN, Zöller I, Gieselmann V. A mammalian fatty acid hydroxylase responsible for the formation of α-hydroxylated galactosylceramide in myelin. Biochem J 2005; 388:245-54; PMID:15658937; http://dx.doi.org/10.1042/BJ20041451
   Google Scholar
• Fukunaga M, Li TQ, van Gelderen P, de Zwart JA, Shmueli K, Yao B, Lee J, Maric D, Aronova MA, Zhang G, et al. Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci U S A 2010; 107:3834-9; PMID:20133720; http://dx.doi.org/10.1073/pnas.0911177107
   Google Scholar
• Alderson NL, Hama H. Fatty acid 2-hydroxylase regulates cAMP-induced cell cycle exit in D6P2T schwannoma cells. J Lipid Res 2009; 50:1203-8; PMID:19171550 http://dx.doi.org/10.1194/jlr.M800666-JLR200
   Google Scholar
• Kota V, Hama H. 2′-Hydroxy ceramide in membrane homeostasis and cell signaling. Adv Biol Regul 2014; 54:223-30; PMID:24139861; http://dx.doi.org/; http://dx.doi.org/10.1016/j.jbior.2013.09.012
   Google Scholar
• Uchida Y, Hama H, Alderson NL, Douangpanya S, Wang Y, Crumrine DA, Elias PM, Holleran WM. Fatty acid 2-hydroxylase, encoded by FA2H, accounts for differentiation-associated increase in 2-OH ceramides during keratinocyte differentiation. J Biol Chem 2007; 282:13211-9; PMID:17355976; http://dx.doi.org/10.1074/jbc.M611562200
   Google Scholar
• Bras J, Singleton A, Cookson MR, Hardy J. Emerging pathways in genetic Parkinson disease: Potential role of ceramide metabolism in Lewy body disease. FEBS J 2008; 275:5767-73; PMID:19021754; http://dx.doi.org/10.1111/j.1742-4658.2008.06709.x
   Google Scholar
• Lei X, Zhang S, Bohrer A, Bao S, Song H, Ramanadham S. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase. Biochemistry 2007; 46:10170-85; PMID:17685585; http://dx.doi.org/10.1021/bi700017z
   Google Scholar
• Ben-David O, Futerman AH. The role of the ceramide acyl chain length in neurodegeneration: involvement of ceramide synthases. Neuromolecular Med 2010; 12:341-50; PMID:20502986; http://dx.doi.org/10.1007/s12017-010-8114-x
   Google Scholar
• Levi S, Finazzi D. Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms.Front Pharmacol 2014; 5:99; PMID:24847269; http://dx.doi.org/10.3389/fphar.2014.00099
   Google Scholar
• Horowitz MP, Greenamyre JT. Mitochondrial iron metabolism and its role in neurodegeneration. J Alzheimers Dis 2010; 20 Suppl 2:S551-68; PMID:20463401
   Google Scholar
• Andreyev AY, Tsui HS, Milne GL, Shmanai VV, Bekish AV, Fomich MA, Pham MN, Nong Y, Murphy AN, Clarke CF, et al. Isotope-reinforced polyunsaturated fatty acids protect mitochondria from oxidative stress. Free Radic Biol Med 2015; 82:63-72; PMID:25578654; http://dx.doi.org/10.1016/j.freeradbiomed.2014.12.023
   Google Scholar
• Jin H, Kanthasamy A, Ghosh A, Anantharam V, Kalyanaraman B, Kanthasamy AG. Mitochondria-targeted antioxidants for treatment of Parkinson disease: preclinical and clinical outcomes. Biochim Biophys Acta 2014; 1842:1282-94; PMID:24060637; http://dx.doi.org/10.1016/j.bbadis.2013.09.007
   Google Scholar
• Murphy MP. Antioxidants as therapies: can we improve on nature? Free Radic Biol Med 2014; 66:20-3; PMID:23603661; http://dx.doi.org/10.1016/j.freeradbiomed.2013.04.010
   Google Scholar
• Smith RA, Murphy MP. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci 2010; 1201:96-103; PMID:20649545; http://dx.doi.org/10.1111/j.1749-6632.2010.05627.x
   Google Scholar